KLC2 and neoplasm: This comprehensive approach facilitated the identification of a LINC00152-driven ceRNA network in human HCC, in which the limited bioavailability of miR-143a-3p leads to upregulation of Kinesin Light Chain 2 (KLC2) and consequently increased tumor cell proliferation and migration.